Navigation Links
Bilcare and CSIR to Partner on nonClonableID Technology for Authentication of Drugs
Date:5/30/2012

PUNE, India, May 30, 2012 /PRNewswire/ --

Council of Scientific and Industrial Research (CSIR) under its New Millennium Indian Technology Leadership Initiative (NMITLI) Scheme has approved the implementation of the project entitled "Customized adaptation of nonClonableID technology to establish authenticity of medical products" by M/S. Bilcare Limited, Pune, India. Dr. Praful Naik, Executive Director & Chief Scientific Officer, Bilcare Limited has been designated as the Principal Investigator for the project.

One of key challenges facing India in the pharmaceutical space, both in domestic and export sectors is that of counterfeit drugs with dire implications to not only the pharmaceutical companies but also government authorities and the general public. In this context, product accountability and traceability has been recognized as a critical need for providing quality medical products. The issue covers not only detecting counterfeits or eliminating illegal duplicates but more importantly to also ensure that medicine of genuine origin is consumed by the patients.

The CSIR-NMITLI-Bilcare team has been assigned the challenge of demonstrating the ability of a novel nonClonableID technology to address the unmet needs in medical product authentication and patient safety. The nonClonableID technology, based on novel aspects of material science and utilizing the law of randomness, shall create unique non-duplicable fingerprints. These fingerprints when processed, digitized and activated can function as unique identification tags. The key objectives of the CSIR-NMITLI project, is to demonstrate the utility of the nonClonableID tags in establishing product accountability through secured traceability from the point of origin to the point of dispensation, authenticity check and establishing e-pedigree; and also in improving medication compliance by patients.

This Public-Private Partnership will allow CSIR and Bilcare to advance research areas
'/>"/>

SOURCE Hanmer MSL Communication Pvt Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
6. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
7. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
8. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
9. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
10. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
11. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 30, 2014 ... addition of the  "Process Validation in the US ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,Key topics ... Based Approach to Process Validation for Pharmaceutical and ... FDA Process Validation Guidance EU ...
(Date:10/31/2014)... 31, 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ... , Isis Pharmaceuticals, Third Quarter 2014 Financial Results ... at 11:30 a.m. ET / 8:30 a.m. PTWhere: ... Internet. Simply log onto our website listed above. If ... a replay of the webcast will be available for ...
(Date:10/31/2014)... Ill., Oct. 31, 2014  AbbVie (NYSE: ... the third quarter ended Sept. 30, 2014. ... performance of our business with double-digit growth from ... business grew nearly 14 percent in the quarter ... chief executive officer, AbbVie.  "We exceeded our outlook ...
Breaking Medicine Technology:Process Validation in the US and EU (Workshop, London) 2Process Validation in the US and EU (Workshop, London) 3Process Validation in the US and EU (Workshop, London) 4Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call 2Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call 3AbbVie Reports Third-Quarter 2014 Financial Results 2AbbVie Reports Third-Quarter 2014 Financial Results 3AbbVie Reports Third-Quarter 2014 Financial Results 4AbbVie Reports Third-Quarter 2014 Financial Results 5AbbVie Reports Third-Quarter 2014 Financial Results 6AbbVie Reports Third-Quarter 2014 Financial Results 7AbbVie Reports Third-Quarter 2014 Financial Results 8AbbVie Reports Third-Quarter 2014 Financial Results 9AbbVie Reports Third-Quarter 2014 Financial Results 10AbbVie Reports Third-Quarter 2014 Financial Results 11AbbVie Reports Third-Quarter 2014 Financial Results 12AbbVie Reports Third-Quarter 2014 Financial Results 13AbbVie Reports Third-Quarter 2014 Financial Results 14AbbVie Reports Third-Quarter 2014 Financial Results 15AbbVie Reports Third-Quarter 2014 Financial Results 16AbbVie Reports Third-Quarter 2014 Financial Results 17AbbVie Reports Third-Quarter 2014 Financial Results 18AbbVie Reports Third-Quarter 2014 Financial Results 19AbbVie Reports Third-Quarter 2014 Financial Results 20AbbVie Reports Third-Quarter 2014 Financial Results 21AbbVie Reports Third-Quarter 2014 Financial Results 22AbbVie Reports Third-Quarter 2014 Financial Results 23AbbVie Reports Third-Quarter 2014 Financial Results 24
(Date:10/31/2014)... October 31, 2014 At the start ... families narrowly escaping carbon monoxide poisoning in their homes. ... weeks away, one family-owned, Missouri-based heating and cooling company ... making sure families start the home heating season with ... secure. , Beginning Nov. 1, 2014, E and ...
(Date:10/31/2014)... -- Surgery for low back pain caused by spinal ... you live, a new report says. "Nearly 80 ... some point in their lives, and about 30 million ... spine problem," co-author Brook Martin, of the Dartmouth Institute ... college news release. In spinal stenosis, thickening of ...
(Date:10/31/2014)... DARIEN, IL – New research suggests that insomnia is ... crashes and other unintentional fatal injuries. The results underscore ... of the National Healthy Sleep Awareness Project. , Results ... in a dose-dependent manner with the number of insomnia ... were 2.8 times more likely to die from a ...
(Date:10/31/2014)... October 31, 2014 The Suspension Revolution ... workout program was developed by Dan Long, a suspension ... as a fitness professional and life coach. The author ... having toned muscles is not impossible , The Suspension ... suspension training. Suspension training promises efficiency when it comes ...
(Date:10/31/2014)... 31, 2014 Florida Air Academy, ... girls in grades 6-12, is taking the lead ... injuries and concussions, becoming the first high school ... (Immediate Post-Concussion Assessment and Cognitive Testing) computerized assessment ... Player' lawsuit grabs the headlines, and the Centers ...
Breaking Medicine News(10 mins):Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3Health News:Spinal Surgery Varies by Region in U.S.: Study 2Health News:Insomnia increases risk of motor vehicle deaths, other fatal injuries 2Health News:Suspension Revolution Review Reveals Dan Long's New Suspension Workout Plan 2Health News:Florida Air Academy Tackling Concussions Head-On 2Health News:Florida Air Academy Tackling Concussions Head-On 3
... byproduct even showed protection for women, study finds, , , ... byproduct that some research has linked to certain cancers, ... and may even offer slight protection for women, new ... than 120,000 men and women, Dutch researchers reported that ...
... of the American Academy of Disaster Medicine,s (AADM), Gary ... from a disaster medicine perspective on the recent swine ... why improvements are needed to the U.S. public health ... or pathogen; how disaster medicine specialists are helping other ...
... In conjunction with DURECT Corporation,s (Nasdaq: DRRX ... invited to listen to the conference call that will be ... at 4:30 pm Eastern Time (1:30 pm Pacific Time).A live ... DURECT,s homepage at http://www.durect.com ...
... In the wake of media reports on the outbreak ... services company, is offering advice to travelers who may already ... take.Over one million American businesspeople, expatriates, students studying abroad and ... offers five basic tips:, , ...
... Offers Significant Improvement - , , CHICAGO ... at the American Urological Association,s (AUA) Annual Conference show ... and sustained improvements of both irritative and obstructive urinary ... within three to four days of starting treatment. ...
... deaths are likely , , TUESDAY, April 28 (HealthDay News) -- ... United States continued to climb Tuesday, to 64, with all ... York City high school that had previously reported 18 cases ... are 64 confirmed cases in the United States in five ...
Cached Medicine News:Health News:Acrylamide Doesn't Raise Lung Cancer Risk 2Health News:Acrylamide Doesn't Raise Lung Cancer Risk 3Health News:American Academy of Disaster Medicine's (AADM) President Comments on U.S. Public Health System, Discusses Swine Flu Infection and Prevention 2Health News:American Academy of Disaster Medicine's (AADM) President Comments on U.S. Public Health System, Discusses Swine Flu Infection and Prevention 3Health News:American Academy of Disaster Medicine's (AADM) President Comments on U.S. Public Health System, Discusses Swine Flu Infection and Prevention 4Health News:Combating Swine Flu: HTH Worldwide Offers Tips to Travelers 2Health News:Combating Swine Flu: HTH Worldwide Offers Tips to Travelers 3Health News:Presented Data Confirm That RAPAFLO(TM) (silodosin) Provides Rapid, Highly Effective, Symptom Relief for Benign Prostatic Hyperplasia (BPH) Patients 2Health News:Presented Data Confirm That RAPAFLO(TM) (silodosin) Provides Rapid, Highly Effective, Symptom Relief for Benign Prostatic Hyperplasia (BPH) Patients 3Health News:Presented Data Confirm That RAPAFLO(TM) (silodosin) Provides Rapid, Highly Effective, Symptom Relief for Benign Prostatic Hyperplasia (BPH) Patients 4Health News:Presented Data Confirm That RAPAFLO(TM) (silodosin) Provides Rapid, Highly Effective, Symptom Relief for Benign Prostatic Hyperplasia (BPH) Patients 5Health News: U.S. Swine Flu Cases Surpass 60 2Health News: U.S. Swine Flu Cases Surpass 60 3
... Increase profitability by ... with simple test,sequences ... administered by ancillary ... than 5 minutes. ...
Holladay Contract Acuity Test provides a more sensitive evaluation for testing visual functions than standard acuity charts....
Vectograms are the standard for vision training. They are available in fixed or variable,styles to accommodate unlimited base-in and base-out training. Each vectogram,includes one pair,of standard 3-...
... Designed to Meet All ... Binocular Cross Cylinder Horizontal and ... Associated Phoria, Binocular Visual Acuity ... Range Monocular Cross Cylinder, Random ...
Medicine Products: